Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis.

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Lymph node (LN) status and burden are critical for bladder cancer patient outcomes post-cystectomy.
• Current staging systems may benefit from incorporating lymph node density.
• This study examines LN density's prognostic value in LN-positive bladder cancer.

Purpose of the Study:

• To investigate the association between lymph node density and clinical outcomes in bladder cancer patients with lymph node-positive disease.
• To evaluate the utility of lymph node density as a prognostic marker.

Main Methods:

• A comprehensive literature search was conducted across major databases (PubMed, SCOPUS, Web of Science, Cochrane Library).
• A meta-analysis was performed on 14 studies including 3311 patients.
• Prognostic associations with disease-free survival (DFS), disease-specific survival (DSS), and overall survival (OS) were analyzed.

Main Results:

• Higher LN density was significantly associated with poorer disease-specific survival (HR 1.53; 95% CI, 1.23-1.89).
• A significant association was found between higher LN density and poorer overall survival (HR 1.45; 95% CI, 1.11-1.90).
• No significant heterogeneity was observed for DFS and OS, but it was present for DSS.

Conclusions:

• Lymph node density is an independent predictor of clinical outcomes in lymph node-positive bladder cancer patients.
• LN density shows potential for enhancing future bladder cancer staging systems.
• Improved prognostic classification of LN-positive bladder cancer may be achieved using LN density.